XM does not provide services to residents of the United States of America.
L
L

LambWeston

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Repeated alerts on Lamb Weston's forecast withdrawn

ADVISORY-Repeated alerts on Lamb Weston's forecast withdrawn Aug 5 (Reuters) - Multiple alerts on Lamb Weston's LW.N forecast, filed between July 19 and July 29, have been withdrawn as they were repeatedly published from various releases over the period. For alerts on Lamb Weston's earnings reported on July 24, click nPLX0C3926 nTUA9XQL5Y STORY_NUM
L

Lamb Weston Outlook FY Adjusted EPS USD 5.5-5.65

BRIEF-Lamb Weston Outlook FY Adjusted EPS USD 5.5-5.65 Jul 30 (Reuters) - Lamb Weston outlook FY sales USD 6,540-6,600 million.
L

Alerts and brief on Lamb Weston's annual forecast from law firm's release withdrawn

ADVISORY-Alerts and brief on Lamb Weston's annual forecast from law firm's release withdrawn Alerts and a brief on Lamb Weston's LW.N full-year revenue and adjusted earnings-per-share forecast were inadvertently and incorrectly published from a law firm's press release and have been withdrawn. Lamb Weston reported its fourth-quarter results on July
L

U.S. Edwards Lifesciences, National Bank Holdings, Sage Therapeutics

U.S. RESEARCH ROUNDUP-Edwards Lifesciences, National Bank Holdings, Sage Therapeutics July 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Edwards Lifesciences, National Bank Holdings and Sage Therapeutics, on Thursday. HIGHLIGHTS * Edwards Lifesciences Corp EW.N : JP Morgan cuts to neutral from overweight * National Bank Holdings Corp NBHC.N : Piper Sandler cuts to neutral from overweight * Sage Therapeutics Inc S
A
A
C
C
G
S
C
E
H
I
A
A
E
L

Lamb Weston Outlook FY Adjusted EPS USD 5.5-5.65

BRIEF-Lamb Weston Outlook FY Adjusted EPS USD 5.5-5.65 Jul 25 (Reuters) - Lamb Weston outlook FY sales USD 6,540-6,600 million.
L

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.